Aurdan Capital Management LLC Acquires Shares of 19,333 UnitedHealth Group Incorporated (NYSE:UNH)

Aurdan Capital Management LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 19,333 shares of the healthcare conglomerate's stock, valued at approximately $9,780,000. UnitedHealth Group makes up about 3.8% of Aurdan Capital Management LLC's investment portfolio, making the stock its 6th biggest position.

Several other hedge funds and other institutional investors have also made changes to their positions in UNH. Norges Bank bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $6,375,744,000. Raymond James Financial Inc. bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $1,914,740,000. Amundi lifted its holdings in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock worth $3,183,132,000 after buying an additional 2,991,470 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after acquiring an additional 2,301,010 shares in the last quarter. Finally, Proficio Capital Partners LLC grew its holdings in UnitedHealth Group by 76,830.4% during the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock worth $955,388,000 after acquiring an additional 1,886,186 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

UNH has been the topic of several recent research reports. Oppenheimer dropped their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Mizuho lowered their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Deutsche Bank Aktiengesellschaft lowered their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a report on Wednesday, May 14th. JPMorgan Chase & Co. lowered their target price on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a research note on Thursday, May 15th. Finally, TD Securities restated a "hold" rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and an average target price of $441.87.

Insider Buying and Selling

In other news, CEO Stephen J. Hemsley bought 86,700 shares of the business's stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the purchase, the chief executive officer now owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO John F. Rex bought 17,175 shares of the business's stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the purchase, the chief financial officer now directly owns 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders have bought 109,408 shares of company stock worth $31,607,768. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded down $0.58 during trading hours on Tuesday, reaching $294.99. 20,069,744 shares of the company's stock were exchanged, compared to its average volume of 6,655,522. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a market capitalization of $267.60 billion, a P/E ratio of 19.03, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The business has a fifty day moving average of $448.25 and a two-hundred day moving average of $501.48. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the firm posted $6.91 EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.